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The skin is the organ that receives the greatest exposure to light and shows a high-amplitude circadian rhythm in
epidermal cell proliferation. We have previously demonstrated that the skin barrier function has a signiﬁcant
circadian rhythm. Corticosteroids (CS) are the most commonly used topical treatment in dermatology. Time-
dependent differences in their efﬁcacy and side-effects would be of considerable interest. The aims of the current
study were to examine time-dependent cycles in the effect of topical CS application in healthy and irritated skin on
skin blood ﬂow and its relationship to barrier function. Twenty clinically healthy, diurnally active subjects were
examined at eight and nine time points over a 24 or 28 h span respectively, using non-invasive skin bioengineering
techniques of laser Doppler imaging, a transepidermal water loss (TEWL) device and a skin thermometer in a 28 h
session. The results of this current study demonstrate circadian and ultradian (12 h) variations in skin blood ﬂow. A
signiﬁcant correlation was found between skin temperature and skin blood ﬂow but not with TEWL. Circadian and
ultradian rhythms are maintained during treatment with high-potency and mid-potency CS in healthy skin. These
rhythms persist during stratum corneum disruption with and without CS application.
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The human organism shows an intricate time structure
consisting of rhythms in multiple frequencies superimposed
upon trends like child development and aging (Touitou and
Haus, 1992). Circadian rhythms of about 24 h periods that
are found ubiquitously in human cells, tissues, organs, and
in the organism as a whole are prominent. Many circadian
rhythms are genetically fixed and synchronized by light
perceived by the retina and the light stimulus related to the
suprachiasmatic nuclei (SCN) of the hypothalamus, which
acts as a central pacemaker that regulates many rhythmic
functions in the body (Rietveld, 1992; Gilette and Tischkan,
1999). The skin is the organ that receives the greatest
exposure to light and shows a high-amplitude circadian
rhythm in epidermal cell proliferation. This leads to the
possibility of an interaction of local oscillator functions in the
skin with light as the environmental synchronizer (Zanello
et al, 2000; Kawara et al, 2002). Circadian and other
rhythms have been found in a variety of skin-related
variables. One of the most important roles of the skin is to
generate a semipermeable barrier, to protect against
transcutaneous water loss. This barrier is located in the
stratum corneum. Recently, we and others (Yosipovitch
et al, 1998; Denda and Tsuchiya, 2000; Le Fur et al, 2001)
have shown a time-dependent variation in the stratum
corneum barrier of human skin. These studies suggest that
the skin permeability barrier is higher during the night and
evening than in the morning, and that the resorption,
efficacy, and side effects of many drugs applied as patch,
gel, or in other forms to the skin surface may vary as a
function of the time of treatment. Another factor that may
affect the efficacy of topical application is the skin blood
flow rate, which has recently been shown to be circadian
periodic with a peak during the late afternoon and night
hours (Smolander et al, 1993; Caspary et al, 1997).
Topical corticosteroids (CS) are the most commonly used
drugs in dermatologic medicine. Time-dependent differ-
ences in their efficacy and side effects would be of
considerable interest. A large-amplitude circadian rhythm
in the percutaneous absorption of CS may have practical
implications for topical CS and other topical agents
administration. When the stratum corneum is damaged by
tape stripping, a series of reparative processes is immedi-
ately accelerated and the barrier recovers to its original level
(Elias and Menon, 1991). This process includes exocytosis
of lipid containing lamellar bodies in the upper epidermis
lipid synthesis and metabolism. Whether this process is
time dependent is important in common clinical situations
Abbreviations: CS, corticosteroids; TEWL, transepidermal water
loss; LDPI, laser Doppler imager; SCN, suprachiasmatic nuclei;
MESOR, midline estimating statistic of the rhythm; PLSD,
protected least significant difference
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such as irritant dermatitis and atopic dermatitis where the
barrier function is disrupted. Other factors that may
influence barrier permeability are short-term application of
topical CS, psychological stress, and sex hormones (Garg
et al, 2001; Kao et al, 2001, 2003). Therefore, time-
dependent variations in skin irritancy due to application of
CS would be of clinical importance.
In this study, we examined the possible connection
between timing of skin physiologic events in stratum
corneum and skin blood vessels in relation to application
of CS to healthy skin and irritated skin. The specific object-
ives were to determine (1) whether the vasoconstrictive
effect of topical CS application is time dependent in healthy
skin, (2) whether the skin irritation by tape stripping has a
significant time-dependent effect on barrier function, and (3)
whether the effects of topical application of CS in irritated
skin are time dependent. The potential clinical implications
of the results are discussed.
Results
Study 1
Basal skin blood ﬂow demonstrates circadian and ultradian
rhythmicity The basal skin blood flow shows a circadian
variation in measurements both over the proximal and distal
forearm with a rhythm described by 24 h population mean
cosinor (p¼0.04, p¼ 0.02, respectively). Superimposed
upon the circadian periodicity is an ultradian rhythm of
about 12 h, which is expressed in the chronograms both
from the proximal and from the distal forearm measure-
ments but reaches statistical significance only in measure-
ments of distal forearm (p¼0.01). Twenty-four percent of
the total variability can be explained by this ultradian
rhythm.
The time-dependent variations in the measurements
were confirmed by one-way ANOVA for the absolute and
normalized data over the distal forearm and the normalized
values over the proximal forearm.
The acrophase of the 24 h cosinor curve best fitting to
the data was 18:56 (95% CI 12:20–22:36) for the proximal
forearm and 18:56 (95% CI 14:56–23:52) for the distal
forearm. The peaks of the superimposed 12 h ultradian varia-
tions were between 13:00 and 14:00 and between 01:00 and
02:00. Of interest is the deep trough of the circadian rhythm
with the lowest blood flow in both measurements found at
08:00 (Fig 1).
The circadian rhythm of skin blood ﬂow is maintained under
treatment with CS The basal measurements obtained were
used for comparison with the values obtained after CS
application at comparably located sites. The circadian
mean in the clobetasol-treated skin sites was about 13%
lower than in the untreated sites as examined by a paired t
test (paired t value¼5.8; p¼0.001) (Fig 1). The circadian
amplitude remained similar, 0.04 V (95% CI 0.01–0.06) at
the treated site versus 0.03 V (95% CI 0.003–0.074) at the
untreated sites. The circadian acrophase in the population
mean cosinor of the clobetasol-treated skin site was 18:28
(95% CI 14:32–21:12), with the highest values measured at
14:00. A 12 h rhythm was not statistically verified at the
po0.05 level by cosinor (Table I and Fig 1). As in the
baseline measurements, there was a deep circadian trough
at 08:00 in the clobetasol-treated skin, which in the Fisher
PLSD (F) test was significantly different from the measure-
ments at all other times. The CS effect (difference baseline–
treated) was recognizable in the night and morning
measurements (20:00–12:00) but not in the measurements
at 14:00–18:00.
At the mometasone-treated site, the circadian mean was
similarly lower by about 12% as examined by a paired t test
(paired t value¼ 4.9; p¼ 0.001). The peak blood flow was at
14:00 with the nadir at 08:00 (Fig 1). The circadian rhythm
is detectable by the population mean cosinor with an
amplitude of similar extent as the baseline values 0.05 V
(95% CI 0.03–0.06) in the treated site versus 0.03 V (95% CI
0.003–0.07) in the untreated sites. Thirty percent of the total
variability is explained by the 24 h rhythm. The circadian
acrophase also occurs during the early evening (18:00, 95%
CI 16:28–19:56).
In the mometasone-treated sites, there is a 12 hour
rhythm component superimposed upon the circadian
rhythm, which accounts for 40% of the total variability
encountered and shows peaks around 02:00 and 14:00. A
deep trough of the circadian variation is found at 08:00. No
significant changes were noted in skin blood flow as
measured by LDPI between the types of corticosteroids. A
steroid effect (difference baseline-treated skin) was recog-
nizable in the night and morning measurements (20:00–
12:00) but not in measurements at 14:00–18:00 in both
treatment groups. There were no differences between the
‘‘mid-potency’’ (mometasome) and the ‘‘high-potency’’
Figure1
Time dependent variations of skin blood flow on the volar forearm.
Measurements were performed in nine study subjects at 3 h intervals
during a 24 h period. Data presented of baseline measurements (  ),
after application of mometasone (’) and colbetasol (m). The mean
values of each group of subjects were determined for each variable at
each time point and are shown with their standard errors as time plots.
Time dependence was found; a deep circadian trough at 8:00 was
noted in baseline as well as in both treatment arms. Peak flows were
noted at 20:00 for baseline measurements and smaller ones at 14:00
for all groups. Analysis by the cosinor method detected circadian
rhythms of 24 h in all three groups and ultradian rhythms of 12 h in the
mometasone-treated skin (see also Table I). The light-off period is
indicated as a bold line on the time axis.
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(clobetasol) steroid upon skin blood flow under the
conditions of this study.
Forearm skin temperature correlates with skin blood
ﬂow There was a positive correlation between basal skin
blood flow and skin temperature on the forearm (r¼0.28,
F¼ 6.02, p¼0.02), which became more prominent after
treatment with colbetasol (r¼0.33, F¼ 8.8, p¼0.004) and
with mometasone (r¼0.35, F¼ 9.9, p¼0.002).
No relationship was noted between barrier permeability
as expressed by TEWL and the maximal effect of corti-
costeroids.
Study 2
Circadian rhythm of barrier function is maintained following
tape stripping and after pre-treatment with mometasone
After skin irritation, TEWL showed a similar time-dependent
pattern to baseline measurements as in intact skin (Fig 2).
As expected after tape stripping irritation, the TEWL is, at all
time points measured, markedly elevated over the values
obtained in undisturbed skin. Cosinor analysis does not
attain a statistically significant description of a 24 h or a 12 h
rhythm p¼0.06 (Table I). There is however a statistically
significant difference between peak and trough values in an
F-test. Pre-treatment with mometasone slightly reduced the
elevated TEWL after skin irritation during the night hours
only, with no effect in the measurements between 14:00 and
20:00. There was a circadian variation which, apart from an
earlier acrophase, was similar to that seen in untreated skin
(Fig 2). The absolute values did not allow statistically
significant 12 or 24 h rhythm detection, but the one-way
ANOVA for time recognized differences between time points
(Table I). The peak times of TEWL in the irritated skin with
and without pre-treatment are similar to the time found in
study 1 in non-irritated and non-treated skin and those in
study 2 baseline measurements in non-treated skin.
Circadian rhythmicity in skin blood ﬂow after tape stripping
Skin blood flow measurements in irritated skin had a
temporal pattern similar to baseline measurements in intact
skin, but a 90% higher mean perfusion (Fig 3). Skin blood
flow measurements showed a significant circadian rhythm
before and after skin irritation, with the actually measured
peaks at 11:00 and the peak time of the best-fitting cosine
curve (acrophase) at 12:04 (95% CI 10:48–13:28) and 13:12
(95% CI 08:40–16:56), respectively. This is earlier in the day,
a phase advance, in comparison to the basal skin blood
flow in study 1. The baseline data did not attain statistical
significance in the 12 h cosinor with the absolute values
(Table I) but did with the normalized data. A 12 h rhythm in
the skin blood flow is not detectable by cosinor analysis
after irritation (Table I). This may be due to the greater
variability encountered after skin irritation.
Table I. Analysis of variance of time-dependent changes and population mean cosinor of 24 h and 12 h rhythms of TEWL, and skin
blood ﬂow with and without topical application of CS on the forearm
Variables ANOVA p value
Population mean
24 h cosinor p value
Population mean
12 h cosinor p value
TEWL baseline 0.002 ns 0.02
TEWL after tape stripping 0.033 ns ns
TEWL after tape stripping with pre-treatment
with mometasone
0.028 ns ns
Skin blood flow baseline first study ns 0.027 ns
Skin blood flow with mometasone 0.0002 0.001 0.004
Skin blood flow with colbetasol propionate 0.05 0.009 ns
Skin blood flow baseline second study 0.0001 0.001 0.05
Skin blood flow after tape stripping ns 0.015 ns
Skin blood flow after tape stripping in pre-treated skin with mometasone 0.001 0.002 ns
ns, not significant.
Figure2
Time-dependent variations of TEWL on the forearm. Measurements
were performed on the volar forearm of 11 study subjects at 3 h
intervals during a 28 h period. Data presented of baseline measure-
ments (  ), after tape strippings (’), and after tape stripping with pre-
treatment with mometasone (m). The mean values of each group of
subjects were determined for each variable at each time point and are
shown with their standard errors as time plots. A time dependence was
found with ANOVA for all three groups, and population mean cosinor for
12 h rhythm was noted in baseline measurements (see also Table I).
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Skin blood ﬂow after tape stripping with pre-treatment by
mometasone maintains circadian rhythmicity Skin blood
flow in irritated skin after pre-treatment with mometasone
0.1% had a similar time-dependent pattern as the baseline
measurements and untreated irritated skin (Fig 3). There
was a highly statistically significant circadian rhythm in the
pre-treated subjects without a significant 12 h variation
(Table I). The acrophase (12:32 [95% CI 10:16–15:00]) was
similar to that of the untreated irritated skin and the baseline
measurements. A lowering of LDPI by mometasone was
observed during the night-time in the pooled data between
20:00 and 05:00 (paired t-value¼ 3.06, p¼0.003). There
was no such effect during daytime.
Discussion
The results of this study show circadian and ultradian
variations in skin blood flow and barrier function, which are
maintained during CS treatment in healthy and irritated skin.
The time-dependent variations in skin blood flow are in
agreement with recent studies on healthy skin and the skin
of patients with mild vascular disease (Houben et al, 1994;
Caspary et al, 1997). The mometasone furoate- and clobe-
tasol propionate-treated sites showed similar circadian and,
in addition, 12 h ultradian variations. Interestingly, although
clobetasol propionate is considered to be a more potent CS
than mometasone furoate, the effects of both drugs on skin
blood flow were similar. LDPI blood flow measurements
have been shown recently to provide reliable and accurate
data to determine the degree of vasoconstriction (Sommer,
1998), and it seems this technique provides an accurate
assessment of the vasoconstrictive effects of CS.
The most consistent observation is the daily low cuta-
neous blood flow during the morning hours. The highest
values are found usually during the afternoon and early
evening, with a second peak in the late evening before sleep
onset. There is a wide variation in the acrophase of the
cosinor as expressed by the large 95% confidence interval.
This is in part due to the superimposed ultradian (12 h)
variation, with a second peak prior to sleep onset that leads
to a non-sinusoidal shape of the circadian variation. The
secondary peak, which by cosinor analysis appears to
indicate a 12 h rhythm, may be an expression of the shift in
heat distribution from the core to the periphery (as measured
by an abrupt increase in peripheral skin temperature taking
place before sleep onset) (Krauchi and Wirz-Justice, 2001).
A secondary peak is not recognized by the same statistical
procedure in temperature obtained at the forehead of the
same patients (data not shown). The low skin blood flow in
the morning may be related to high plasma catecholamine
levels and the related increased peripheral resistance found
during the early morning hours (Elherik et al, 2002).
These results differ from the study by Pershing et al
(1994), who described a circadian difference in the action of
topical betamethasone dipropionate application at 16:00
that produced more extensive changes in skin blanching as
a measure of vasoconstriction than morning application at
09:00 in the same subject. The methods used in the latter
study however were based on visual measurement with a
chromameter to evaluate the vasoconstrictive effect of CS
and did not measure blood flow. Furthermore, the limitation
of the study to only two time points does not allow the
description of a circadian rhythm.
The results of this study reveal time-dependent differ-
ences in skin physiology, which may affect the absorption of
topical drugs in undisturbed as well as irritated skin. Both
therapeutic and toxicologic considerations have to be
considered. The maximal therapeutic effect, as suggested
by the steroid effect upon blood flow in irritated skin, seems
to occur after application during the later evening hours.
This corresponds in timing to the nocturnal rise in infla-
mmatory activity with early morning peak in IL-6 as inflamma-
tory mediator (Haus and Smolensky, 1999), which has led to
the consideration of a dosing of CS around 02:00 in patients
with rheumatoid arthritis (Arvidson et al, 1997). From this
viewpoint, it may be advantageous to dose topical CS at
night in acute inflammatory states where a high concentration
of the drug is required and a rapid drug effect is desired in
the late afternoon or evening, rather than giving the CS in
the morning when a lesser immediate effect would have to be
expected. Similar dosing times have been found to be
advantageous in the anti-inflammatory steroid medication of
bronchial asthma (Kraft, 1999; Smolensky et al, 1999). Other
clinical implications of this study are that the patients’ biologic
timing and the time patients are examined for skin blood flow
should be taken into account in studies as well as clinical
investigations. In addition, we found that the peripheral skin
perfusion seems to follow the same overall pattern as body
temperature and is involved most probably in the circadian
rhythm of body core temperature (Houben et al, 1994). This
has a significant effect on transdermal drug delivery. It has
been previously shown that heat-induced local vasodilatation
and acceleration of skin blood flow affect drug passage
Figure 3
Time-dependent variations of skin blood flow in the volar forearm
after tape strippings (’), with pre-treatment with mometasone (m)
versus baseline measurements (  ). Measurements were performed
in 11 study subjects at 3 h intervals during a 28 h period. The mean
values of each group of subjects were determined for each variable at
each time point and are shown with their standard errors as time plots.
Skin blood flow had a similar temporal pattern in tape-stripped skin
with and without mometasone to baseline skin blood flow. Peak blood
flow was noted at 11:00. The population mean cosinor for 24 h rhythm
was noted in all three groups. A 12 h rhythm was not noted after skin
irritation (see also Table I).
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through the skin and diffusion from cutaneous and sub-
cutaneous tissues to systemic circulation (Shomaker et al,
2001). It has to be realized, however, that the circadian rhythm
of the pharmacodynamics of a drug does not necessarily
follow the circadian-periodic changes in its pharmacokinetics
(Lemmer and Bruguerolle, 1994).
Our results are of relevance to skin pharmacology. The
recognition of a significant circadian variation in skin blood
flow and skin permeation, which is maintained under barrier
disruption and under topical CS treatments, might result in
the development of treatment strategies for topical applica-
tions taking into account chronopharmacology.
Materials and Methods
Subjects for study no. 1: Nine clinically healthy Chinese (four men
and five women, 31  4.5 y of age) (mean  SD, range 24–36),
who gave informed consent, participated in a 24 h session.
Subjects for study no. 2: Eleven clinically healthy volunteers
(eight Chinese and three Caucasians), who did not participate in
study number 1 (seven men and four women, 30.5  4.7 y of age)
(mean  SD, range 25–39), who gave informed consent, partici-
pated in a 28 h session. Both studies were approved by the
National Skin Center ethics committee. The study was performed
in accordance with guidelines of the Helsinki Principles.
The subjects, all non-smokers, had no skin disease or atopic
history, nor had they used topical or systemic CS preparations in
the previous 1 mo. None of the women were pregnant or taking
oral contraceptives for at least 6 mo. All women were chosen to be
in the luteal phase of their menstrual cycle during the study
(Reinberg et al, 1996), and were instructed to refrain from applying
soaps or moisturizers on the area studied at least 24 h before the
study. All followed a diurnally active living pattern, with rest during
the night on an average from 23:00 to 07:00. During the study,
lights were turned off at 22:30. Study no. 1 occurred during
January 2000, and study no. 2 during the same month a year later.
During both studies, the climate and environment were well
controlled in environmental temperature (221C  11C) and humidity
(50%–60%). All subjects shared the same meals (spicy food,
alcohol, and hot beverages were not permitted during the study)
and engaged in comparable mental and physical activities and rest
periods during the session with a 30 min adaptation period before
each sampling. The patients were seated in a temperature-
controlled room and were instructed not to eat or drink during
that period. Non-strenuous activities such as reading, watching
television, and writing were allowed. The patients wore the same
clothes day and night. They were instructed to wear short-sleeved
shirts, leaving the volar part of the forearm free. They slept with
light blankets, and were instructed not to apply water on the
investigated area during the study. All measurements were
performed while the examinees were in a recumbent position
and their forearms in a horizontal position.
Protocol study no. 1 We measured the effect of a long-acting
mid-potency CS, mometasone furoate 0.1% (Elomet ointment,
Schering Plough, Singapore, Singapore), and a high-potency
corticosteroid, clobetasol propionate (Dermovate ointment, UCB),
UCB, Smyrna, GA on skin blood flow using a scanning laser
Doppler imager (LDPI, LISCA, Linkoping, Sweden), which rapidly
measures blood flux over a 4 cm2 area without contact with the
skin surface. All measurements were conducted at a scanning
distance of 20 cm. The mean perfusion was calculated from 264
pixels. The borders of the measured areas were marked before the
measurement. Baseline measurements prior to drug application
were made both over the proximal and over the distal forearm to
ensure that there are no significant differences in site that can
influence the analysis of the results in sites of drug application.
Skin temperature was measured with an infrared thermometer
type K model (AI 38) (Northlab, Singapore) with a sensitivity of
0.11C. Transepidermal water loss (TEWL) was measured with a
TEWL device (Dermalab, Broomall, Pennsylvania). TEWL values
were registered in g per m2 per h after equilibration of the probe on
the skin for 60 s. Measurements were conducted on the volar part
of both forearms. Eight circular sites 2 cm in diameter were outlined
and numbered 1–8 with a skin marking pen. There was a 2 cm
distance between the sites. The drugs were applied 3 h before
each measurement. Mometasone furoate 0.1% ointment was
applied to one of the marked circles and clobetasol propionate
0.1% ointment to the contralateral forearm. Every 3 h, 20 mL of
each cream was pipetted on the center of a different circle chosen
randomly within the test area and gently massaged for 30 s.
Measurements of skin blood flow laser Doppler imaging were
performed with the PIM Lisca on both sites of drug application
and also in two untreated sites—one on the proximal forearm
and one on the distal forearm—to ensure that there are no
significant differences in measurements between the sites of
application. Measurements were conducted 3 h after drug
application at the following time points: 23:00, 02:00, 05:00,
08:00, 11:00, 14:00, 17:00, and 20:00. Measurements of TEWL and
skin temperature were conducted on untreated sites at the times
mentioned above.
Protocol study no. 2 On both volar forearms on marked sites,
barrier disruption was achieved with 30 tape strippings with
cellophane scotch tape (3M, St Paul, Minnesota) every 3 h. For
each subsequent measurement of barrier function, a different site
was tape stripped and TEWL was measured (altogether eight sites).
On the left forearm, pre-treatment with mometasone furoate 0.1%
ointment was applied 3 h before tape stripping each site. Skin blood
flow and TEWL were measured during the 24 h span every 3 h
consecutively at the following time points: 17:00, 20:00, 23:00,
02:00, 05:00, 08:00, 11:00, and 14:00, 17:00 on treated and
untreated sites of tape-stripped skin and on a non-stripped skin site.
Statistical analysis All values were analyzed in absolutes and
normalized in percent of the 24 h mean value. The percent of mean
emphasizes the periodicity of the variables and eliminates
differences in levels between subjects. The mean values of each
group of subjects were determined for each variable at each time
point, and are shown with their standard errors as time plots in Figs
1–3. Single cosinor curve fits (Nelson et al, 1979) were performed
on each subject’s data over a spectral window, with periods from 6
to 28 h (in 0.5 h intervals), to determine the best-fitting cosine
curves suggesting ultradian (less than a 20 h period) and/or
circadian (20.5–28 h periods) variations. Since the best-fitting
curves in the subjects clustered around 12 and 24 h, the single
cosinor results from the 12 and 24 h fit for each subject were used
as input for a population mean cosinor for the group (Nelson et al,
1979). Population mean cosinors were performed on men and
women separately and on the entire group. Because of the small
numbers, the data presented are on the entire group for each study
(study 1: nine subjects; study 2: 11 subjects). The population mean
cosinor provides the rhythm parameters of the rhythm-adjusted
mean (midline estimating statistic of the rhythm¼MESOR), the
amplitude (the excursion from MESOR to the peak or trough of the
rhythm representing half the peak–trough interval of the fitted
cosine curve), and the acrophase (the peak time of the best-fitting
cosine curve) in relation to local midnight as a phase reference.
Rhythm description by cosinor was accepted when the null
hypothesis for amplitude was rejected in an F test at/below the
0.05 level. In addition, the data of the group were subjected to
analysis of variance (ANOVA) in one-way ANOVA for time. p values
below 0.05 were accepted as indicating statistical significance.
The difference between single time points was determined by the F
test (Fisher PLSD (protected least significant difference) where
appropriate.
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